Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA145819 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Gene expression profiling of immortalized human mesenchymal stem cells with hTERT/E6/E7 transfected MSCs. hTERT may change gene expression in MSCs. Goal was to determine the gene expressions of immortalized MSCs.
2010-09-25 | GSE24338 | GEO
Project description:Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer
| PRJNA126079 | ENA
Project description:Genes induced by partial down-regulation of ARID1A in breast cancer cell
| PRJNA294615 | ENA
Project description:MicroRNA-1 is a candidate tumor suppressor and prognostic marker
| PRJNA145531 | ENA
Project description:Using GINI2 to identify novel mutations in candidate tumor suppressor genes in colon cancer cells
| PRJNA96123 | ENA
Project description:Identification of target genes of tumor suppressor microRNAs in human cancer
| PRJNA132229 | ENA
Project description:Transcriptional profiling of human mesenchymal stem cells comparing normoxic MSCs cells with hypoxic MSCs cells. Hypoxia may inhibit senescence of MSCs during expansion. Goal was to determine the effects of hypoxia on global MSCs gene expression.
2011-02-19 | GSE20463 | GEO
Project description:Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes [human]
| PRJNA272144 | ENA
Project description:The transcription factor c-Myb has been well characterized as an oncogene in several human tumor types, and its expression in the hematopoietic stem/progenitor cell population is essential for proper hematopoiesis. However, the role of c-Myb in mammopoeisis and breast tumorigenesis is poorly understood, despite its high expression in the majority of breast cancer cases (60-80%). We find that c-Myb high expression in human breast tumors correlates with the luminal/ER+ phenotype and a good prognosis. RNAi knock-down of endogenous c-Myb levels in the MCF7 luminal breast tumor cell line increases tumorigenesis both in vitro and in vivo, suggesting a tumor suppressor role in luminal breast cancer. We created a mammary-derived c-Myb expression signature and found it to be highly correlated with a published mature luminal mammary cell signature and least correlated with a mammary stem/progenitor lineage gene signature. These data describe, for the first time, a tumor suppressor role for the c-Myb proto-oncogene in breast cancer that has implications for understanding luminal tumorigenesis and for guiding treatment. refXsample
2010-10-15 | E-GEOD-21371 | biostudies-arrayexpress